Lecrolyn

Sodium cromoglicate, the active ingredient in Lecrolyn, is a mast cell stabilizer presented as an ophthalmic solution for ocular use. It helps control allergic conjunctivitis and vernal keratoconjunctivitis by reducing histamine release in the eyes of affected patients.

GNH USA supplies Lecrolyn as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies, and clinics worldwide under strict quality standards and regulatory compliance. The company manages export logistics, documentation, and post‑market support to ensure reliable availability across diverse healthcare settings.

Lecrolyn, a mast cell stabilizer, is used to manage ocular allergic conditions. - Allergic conjunctivitis: reduces itching, redness and tearing caused by ocular allergy. - Vernal keratoconjunctivitis: decreases inflammation and helps prevent corneal damage in chronic seasonal allergy. - Seasonal allergic conjunctivitis: alleviates eye symptoms during pollen season.

Sodium cromoglicate ophthalmic solution may cause local ocular reactions, most of which are mild and transient.

Common Side Effects: - Burning sensation: transient feeling of heat after instillation. - Stinging: brief sharp discomfort in the eye. - Redness: mild conjunctival hyperemia. - Blurred vision: temporary visual disturbance that resolves quickly.

Serious or Rare Side Effects: - Severe allergic reaction: signs of anaphylaxis such as swelling, difficulty breathing. - Corneal ulcer: rare but serious corneal injury requiring immediate medical attention.

When using Lecrolyn, follow these safety measures. - Avoid contact with contaminated hands: use sterile technique when instilling. - Do not use if solution is discolored or particulate: discard any compromised product. - Consult eye care professional if symptoms persist beyond 7 days: seek evaluation for possible alternative therapy. - Pregnancy and lactation: safety not established; use only if clearly needed after risk assessment. - Concurrent ocular medications: separate instillation by at least 5 minutes to avoid interaction. - Store at room temperature: keep in original container, protect from light and moisture.

Sodium cromoglicate may interact with other ocular products.

Major Interactions (Avoid): - Contact lens solutions containing preservatives: may cause irritation when used together. - Topical ocular steroids: combined use can increase risk of infection.

Moderate Interactions (Monitor Closely): - Systemic antihistamines: may mask ocular symptoms, requiring monitoring. - Other mast cell stabilizers: additive effect could increase local irritation. - Non‑steroidal anti‑inflammatory eye drops: monitor for increased discomfort.